I understand the process but we live in a different world.
I understand the process but we live in a different world. Tell me how Remdisivir got their approvals by proper processes and not having to repeat their one of many trials that showed a positive result and the others stopped prior to being revealed internally as failures. Why didn’t they have to do a phase 4 proof. How did convalescent plasma sneak in with minimal effect?
The fact is we live in what I consider a different time and it’s not just pandemic time. Historically none of the EUA’s would of been approved in a different time even with a pandemic. But the political pressure on the FDA is immense and nothing isn’t impossible. We can call this “ Trumps World “ I am not putting him down politically. But our world is most definitely different with him at the helm. You can say process process process. But I will just say. Trump will change those rules if it fits his agenda. He has done it over and over and he will do it again and again. I am not a fan of him really but I am a realist and when he wants something real like Leronlimab. He will need to back up the reason to approve and not just say that Nader said it had a perfect safety record. His only way to have the public view it as safe IMO is to approve HIV for the use of the safety profile to be documented. The hoops we would have to jump through will be pulled down so we could kindly walk our way to approval. That’s what I would call Trumps World. Anything is possible!.
The simultaneous approval would go along way to getting the confidence of the public back. That’s what he needs. It’s what we all desire. It’s just a matter of telling him that’s what can happen. Then he will make it so... Don’t discount what the Donald can do. Just be amazed at what he has done already and then speculate. Is it possible? Surely you have to believe that he will do anything to gain back the public opinion?
Maybe this is all fiction? Or is it? I give it 50/50 that if the S/C results are good or great that we miraculously get a approval of HIV simultaneously. To me... I am amazed at what he has done already. I believe this isn’t a reach in “ Trumps World “ when politics are involved anything is possible.
By the way, he has upset the Big Pharma apple cart with price match world prices going forward. He is ready to piss them off again if it benefits his agenda. Big Pharma power to hold us back will surely go away now with impact results to make him a hero.
Just remember who I am. The overly optimistic person who’s glass does runneth over.
Probably not likely to happen but I can share my dreams right?
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...
Continue Reading
Chicago Steps into the Quantum Race In a world where cutting-edge tech isn't just desired, it's demanded, Chicago's just put itself on the quantum map with IBM's latest move. The unveiling of IBM Quantum System Two at the University of Chicago marks a milestone not just for the city, but for Illinois at large. This isn't some pie-in-the-sky tech dream—it's a tangible...
Continue Reading
The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...
Continue Reading
Financial Struggles Amid Expansion Efforts Imagine a ship trying to lift anchor while taking on water. That's U Power Limited's latest financials for the first half of 2026 in a nutshell. We're seeing the company, listed under NASDAQ: UCAR, navigating through turbulent financial seas while executing ambitious expansion projects. Revenue Declines Spell Trouble Total net...
Continue Reading
HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...
Continue Reading
A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...
Continue Reading
Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...
Continue Reading
Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...
Continue Reading
A Credit Union Shines in the Limelight Sitting in the honoree section isn't something credit unions are commonly known for, but Sacramento's very own Golden 1 Credit Union just barged into the room with a big win. TIME's inaugural list of America's Best Companies has rolled Golden 1 into the spotlight, solidifying its role not just as a financial leader but as a community...
Continue Reading
Fresh Grounds: CoffeeBarista.com Enters the Brewing Scene Alright, folks, let's cut to the chase. Digital Information Resources, the tech whiz that's been accumulating niche online properties like they're baseball cards, decided it's time to dive headfirst into the caffeinated waters with CoffeeBarista.com. Fancy name for a platform dedicated to everything bean juice,...
Continue Reading
Top 5 Most Recently Viewed Articles
MacKay Shields Announces Appointment of Alison Micucci MacKay Shields, an $151 billion asset management firm, is thrilled to announce that Alison Micucci will take on the role of CEO. Effective from the start of 2025, she will lead the company as it seeks to expand its services and capabilities in the asset management sector. Alison Micucci: A Leader with Vast Experience...
Continue Reading
Shengfeng Development's CEO Takes Major Stake in Company In a significant move reflecting confidence in the company's future, Mr. Yongxu Liu, the Chairman and Chief Executive Officer of Shengfeng Development Limited (NASDAQ: SFWL), purchased 500,000 Class A ordinary shares in the open market recently. This transaction occurred at an average price of $1.289 per share....
Continue Reading
Introduction to New Mortgage Risk Indexes The Smith Enterprise Risk Consortium (SERC) at the University of Maryland's Robert H. Smith School of Business has announced the introduction of two groundbreaking mortgage credit risk indexes. These tools are designed to help lenders, servicers, credit investors, and regulators gauge shifts in the credit risk associated with...
Continue Reading
Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...
Continue Reading
Massive Boost for Nonprofits Across the United States It's not every day you see millions thrown into nonprofit work without some fanfare, right? Unlikely Collaborators just poured a hefty $7.2 million into the coffers of 52 nonprofit outfits scattered across the nation. This spread isn't just about slapping cash on projects—it's about putting Elizabeth R. Koch's...
Continue Reading